jyoti rao,
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat... Randomized Phase II…
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American…
Overview of attention for article published in Journal of Clinical Oncology, May 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Mentioned by
- news
- 9 news outlets
- blogs
- 1 blog
- 23 X users
- patent
- 1 patent
- googleplus
- 1 Google+ user
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 114 Mendeley